Please provide your email address to receive an email when new articles are posted on . The integration of second-generation anti-vascular endothelial growth factor (VEGF) therapies into treatment ...

Measuring macular neovascularization vessel density with OCT-A at the time of anti-VEGF treatment cessation helps estimate the risk of later nAMD recurrence. Higher macular neovascularization (MNV) ...

PORTLAND, Maine--(BUSINESS WIRE)--BerryDunn, a full-service accounting, tax, and consulting firm, will return for the 20 th year to the National Association of Medicaid Directors Fall Conference (NAMD ...

BerryDunn, a full-service accounting, tax, and consulting firm, will return for the 20th year to the National Association of Medicaid Directors Fall Conference (NAMD), taking place in National Harbor, ...

Make sure not to miss this valuable item your first time around. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on ...

In many a school auditorium, a theater kid could be spotted sitting cross-legged with a peanut butter and jelly sandwich, surrounded by peers who had just belted their way through the entire Hamilton ...

Migaldendranib (MGB) is a new class of targeted nanomedicine for the treatment of diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) with a novel mechanism of action ...

Contivue platform with Susvimo received EU CE mark for neovascular AMD treatment, offering continuous ranibizumab delivery via an eye implant. Clinical studies, including Archway and LADDER, ...

Microsoft is betting big on AI. Starting with integrating Bing with ChatGPT, it has implemented AI capabilities in its products. Microsoft Designer is a new product from Microsoft with AI capabilities ...

Purpose To explore the association between early response of different lesions and the number of anti-vascular endothelial growth factor (anti-VEGF) injections in neovascular age-related macular ...

Neovascular age-related macular degeneration (nAMD) is a progressive eye disease characterized by choroidal neovascularization and subretinal hemorrhage and exudation, leading to vision impairment.